To uncover the molecular mechanisms through which LA-CB1 exerts its anti-tumor effects, we performed transcriptomic analysis comparing LA-CB1-treated and DMSO-treated MDA-MB-231 cells. The gene discussed is CNR1; the disease is neoplasm.